CI Cigna Group Stock Outlook 2026: PBM Pivot After Medicare Exit
Cigna Group (NYSE: CI) stock analysis for 2026 covering the Evernorth PBM strategy, Medicare Advantage divestiture to HCSC, regulatory risk from FTC, GLP-1 drug cost exposure, and bull/bear scenarios for US investors.
CI Cigna Healthcare